Skip to content

Clinical trials

Schizophrenia trials in Portugal

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Country / region: Portugal Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20043
20061
20072
20081
20101
20122
20172
20181
20191
20212
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Unknown status3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen-Cilag International NV3
Boehringer Ingelheim2
Eli Lilly and Company2
AstraZeneca1
CEDIARA - Assoc. Solidariedade Social de Ribeira de Fráguas1
Denovo Biopharma LLC1
Faculdade de Motricidade Humana1
Janssen Research & Development, LLC1
Janssen-Cilag Farmaceutica Ltda.1
Lisbon Institute of Global Mental Health - LIGMH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia20
Psychotic Disorders5
Mental Disorders3
Bipolar Disorder1
Mood Disorders1
Motor Skills Disorders1
Schizophrenia, Paranoid1
Status Epilepticus1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.